QGEN - Qiagen NV - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

QGEN is currently covered by 8 analysts with an average price target of $50.21. This is a potential upside of $5.08 (11.26%) from yesterday's end of day stock price of $45.13.

Qiagen NV's activity chart (see below) currently has 76 price targets and 73 ratings on display. The stock rating distribution of QGEN is 40.91% HOLD and 59.09% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.64% with an average time for these price targets to be met of 67.19 days.

Highest price target for QGEN is $54, Lowest price target is $48, average price target is $49.17.

Most recent stock forecast was given by JOHN SOURBEER from UBS on 07-Feb-2025. First documented stock forecast 14-Jul-2015.

Currently out of the existing stock ratings of QGEN, 9 are a HOLD (40.91%), 13 are a BUY (59.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$48

$5.95 (14.15%)

$46

3 months 23 days ago
(07-Feb-2025)

3/8 (37.5%)

$6.66 (16.11%)

28

Hold

$48

$5.95 (14.15%)

$49

4 months 24 days ago
(06-Jan-2025)

3/8 (37.5%)

$3.19 (7.12%)

112

Buy

$54

$11.95 (28.42%)

$54

5 months 20 days ago
(10-Dec-2024)

1/8 (12.5%)

$7.9 (17.14%)

1

Buy

$50

$7.95 (18.91%)

11 months 3 days ago
(27-Jun-2024)

1/3 (33.33%)

$8.87 (21.57%)

57

Hold

$45

$2.95 (7.02%)

$50

1 years 29 days ago
(01-May-2024)

3/3 (100%)

$2.16 (5.04%)

21

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is QGEN (Qiagen NV) average time for price targets to be met?

On average it took 67.19 days on average for the stock forecasts to be realized with a an average price target met ratio 54.64

Which analyst has the current highest performing score on QGEN (Qiagen NV) with a proven track record?

MATTHEW SYKES

Which analyst has the most public recommendations on QGEN (Qiagen NV)?

Matthew Sykes works at GOLDMAN SACHS and has 5 price targets and 4 ratings on QGEN

Which analyst is the currently most bullish on QGEN (Qiagen NV)?

Dan Leonard with highest potential upside - $19.5

Which analyst is the currently most reserved on QGEN (Qiagen NV)?

Derik De Bruin with lowest potential downside - -$15.57

Qiagen NV in the News

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

QIAGEN N.V.’s QGEN first-quarter 2025 adjusted earnings per share (EPS) were 55 cents, and 56 cents at constant exchange rate (CER). The bottom line increased 17% from the year-ago level. Additionally, it surpassed the Zacks Consensus Estimate by 10%. The adjustment excludes the impact of certain non-recurring items, such as business integration, acquisition and restructuring-related...

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical – Biomedical and Genetics sector have probably already heard of Qiagen (QGEN) and Repligen (RGEN). But which of these two stocks is more attractive to value investors? We’ll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?